首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds
【24h】

Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds

机译:抑制碳酸酐酶同种型I,II,IX和XII与仲磺胺酰胺掺入苯并噻唑支架

获取原文
获取原文并翻译 | 示例
           

摘要

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the fundamental reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho/physiological conditions. A series of benzothiazole-based sulfonamides were synthesized and tested as possible CA inhibitors. Their inhibitory activity was assessed against the cytosolic human isoforms hCA I and hCA II and the transmembrane hCA IX and hCA XII. Several of the investigated derivatives showed interesting inhibition activity and selectivities for inhibiting hCA IX and hCA XII over the off-target ones hCA I and hCA II. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds, within the active site of hCA IX.
机译:碳酸酐酶(CAS,EC 4.2.1.1)催化CO2水合在所有生物体中的基本反应,积极参与调节血清毒素/生理条件的调节。 合成了一系列基于苯并噻唑基磺酰胺,并以可能的Ca抑制剂测试。 将其抑制活性评估胞质人同种型HCA I和HCA II以及跨膜HCA IX和HCA XII。 几个研究的衍生物显示出有趣的抑制活性和选择性,用于抑制在偏移HCA I和HCA II上的HCA IX和HCA XII。 此外,使用计算过程来研究该类化合物的结合模式,HCA IX的活性位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号